RxDoctor Payments Data

Gilbert Dominguez, MD

Family Medicine · la Jolla, CANPI 1275601478

Payments from drug & device makers

$12,580in general payments, 2019–2025

Across 608 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Pfizer$773
  • GSK$733
  • Amgen$663
  • Novo Nordisk$572
  • plus $7K from 54 others

What the payments were for

  • Speaking & faculty fees$260%
  • Food & beverage$12,37098%
  • Education$1841%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)81$1,672
AstraZeneca60$1,409
Pfizer36$773
GSK32$733
Amgen(2 entities)32$663
Novo Nordisk30$572
Lilly USA, LLC21$525
Amarin Pharma, Inc.34$506
Novartis31$477
Takeda Pharmaceuticals U.S.A., Inc.21$319
Arbor Pharmaceuticals, Inc.11$238
Esperion Therapeutics, Inc.13$236
Merck12$215
Bayer10$214
Currax Pharmaceuticals LLC12$200
Exact Sciences8$196
Neurent Medical Limited2$193
Antares Pharma, Inc.8$174
Gilead9$170
Zyla Life Sciences, Inc.14$160
Si-bone, Inc.1$145
Otsuka America Pharmaceutical, Inc.7$143
Kowa Pharmaceuticals America, Inc.8$133
Boehringer Ingelheim6$127
Sanofi-aventis U.S. LLC6$127
Sanofi Pasteur Inc.6$122
Inspire Medical Systems, Inc.2$111
Astellas Pharma US Inc4$110
Impel Pharmaceuticals LLC5$107
Eisai Inc.5$100
Impel Pharmaceuticals Inc.5$97
Azurity Pharmaceuticals, Inc.5$96
Medicure Pharma Inc.2$93
Biohaven Pharmaceuticals, Inc.4$92
Tolmar, Inc.5$83
Corcept Therapeutics4$82
Lundbeck LLC4$74
Genentech USA, Inc.4$71
Axsome Therapeutics, Inc.3$67
Acella Pharmaceuticals, LLC3$62
Shire North American Group Inc3$60
Idorsia Pharmaceuticals US Inc3$57
Almatica Pharma LLC2$57
Acerus Pharmaceuticals Corporation3$54
Teva Pharmaceuticals USA, Inc.2$50
Shield Therapeutics Inc1$45
Therapeuticsmd, Inc.2$41
IBSA Pharma Inc.2$41
Biohaven Pharmaceutical Holding Company Ltd.2$39
Bausch Health US, LLC2$34
Verity Pharmaceuticals Inc.1$34
Actelion Pharmaceuticals US, Inc.1$30
Paratek Pharmaceuticals, Inc.1$27
Philips North America LLC1$24
Johnson & Johnson1$23
E.r. Squibb & Sons, L.L.C.1$22
Neurocrine Biosciences, Inc.1$21
Neurelis, Inc.1$21
AMAG Pharmaceuticals, Inc.1$21
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,580 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$895,964
Medicare patients
1,696
Services billed
15,744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$39,547
MounjaroTirzepatide33$38,510
FarxigaDapagliflozin Propanediol31$36,850
EliquisApixaban47$34,720
Repatha SureclickEvolocumab38$30,351
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$21,606
JardianceEmpagliflozin14$17,911
JanuviaSitagliptin Phosphate11$17,319
Praluent PenAlirocumab19$9,308
SynthroidLevothyroxine Sodium93$8,699
VascepaIcosapent Ethyl17$6,872
Testosterone31$6,755
Rosuvastatin Calcium328$4,878
Atorvastatin Calcium343$3,256
PaxlovidNirmatrelvir/Ritonavir17$2,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$572$39,54745 claims
Lilly USA, LLCMounjaro$525$38,51033 claims
PfizerEliquis, Paxlovid$773$37,57964 claims
AstraZenecaFarxiga$1,409$36,85031 claims
GSKTrelegy Ellipta$733$21,60620 claims
Boehringer IngelheimJardiance$127$17,91114 claims
MerckJanuvia$215$17,31911 claims
AbbVieSynthroid$1,672$8,69993 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.

Other family medicine in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →